Broadway Angels and Chronicled Aligned for Growth Phase of Blockchain and Supply Chain Ecosystems with Pre-Series A Investment
SAN FRANCISCO, May 16, 2018 /PRNewswire/ -- Chronicled, Inc. has announced an investment by Broadway Angels in the company's pre-Series A financing. Over the past year, Chronicled, a technology firm using blockchain technology to secure and automate industrial supply chains has grown significantly, adding team members and launching a production-ready platform. The investment from Broadway Angels will help Chronicled to execute on its strategic roadmap.
"Broadway Angels is delighted to invest in Chronicled," said Sonja Perkins, Founder of Broadway Angels. "Blockchain technology will solve some of the biggest problems in enterprise and we view Chronicled as the leader in supply chain."
Broadway Angels represents the top women venture capitalists, founders, and thought leaders in Silicon Valley. Broadway Angels invests in the best companies, with both male and female founders, while diversifying cap tables and showcasing female excellence in investing.
The group includes:
Sonja Perkins, founder of The Perkins Fund, Broadway Angels and Project Glimmer. She spent 22 years at Menlo Ventures and won the "Investor of the Year Award" six times. Sonja has invested in three start-ups that achieved multi billion dollar public company valuations.
Jennifer Fonstad, Partner at Aspect Ventures and co-founder of Broadway Angels. Jennifer spent over 20 years with DFJ and now runs the largest female founded venture capital firm in the world.
Katherine August de Wilde, Vice Chair & Member of Board, First Republic Bank. She is on the boards of SunRun and Eventbrite.
Elen Levy, referred to as the "Most Connected Woman in Silicon Valley" by Fast Company; former Head of Strategic Initiatives and member of Exec Team, LinkedIn.
Shellye Archambeau, former CEO of IBM Asia-Pacific and MetricStream. She currently serves on the boards of Verizon and Nordstrom.
Karen Boezi, former CEO, Redwood Bioscience. Karen was the co-founder and Managing Partner of Thomas McNerney & Partners. She has over 20 years of healthcare private equity experience.
"It is great to have such an influential group of women investing in Chronicled, the future of blockchain, and the larger social movements this technology represents," said Samantha Radocchia, Co-Founder at Chronicled. "We are excited to have strong partners as we strive towards decentralization, inclusion, and responsible global trade."
The investment bridges into a larger Series A round that Chronicled plans to close in 2018. Since its launch in 2014 Chronicled has raised more than $10m in Angel and Seed financing.
About Chronicled Based in San Francisco, Chronicled is a technology company leveraging blockchain and IoT to bring trust, efficiency, and automation to global supply chain ecosystems. The Company is a pioneer in linking physical world economy workflows to blockchain systems and has developed a decentralized protocol and network for supply chain in order to extend trust boundaries and enforce cross-organization business rules without revealing private data. Currently, Chronicled's most active market verticals are Pharmaceuticals, Commodities, and Precious Metals and Minerals.
Revenue
Revenue for the year was $238.5, down $1.4 from sales of $239.9 in 2022. The Company's sales were flat when compared to 2022 and 2021 included a fifteen month period due to the accounting change from September 30 to December 31.
Twelve-month...
Buhler Industries Inc. ("Buhler Industries or the Company"), the manufacturer of Versatile and Farm King brands of farm equipment, has made operational restructuring changes in the first quarter of 2024 that is expected to result in significant full...
Buhler Versatile Inc. ("Versatile"), a wholly owned subsidiary of Buhler Industries Inc. (Buhler Industries or the Company), has received $14.4 million Canadian ($10.7 million USD) in additional long term financing from its majority owner Ba?ak...
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....
In view of the passing of Thomas G. Kamp, a Director on the Board of Directors of The Taiwan Fund, Inc. (TWN) (the "Fund"), on March 20, 2024, the Board has approved amending the size of the Board to four Directors.
The Board will consider later in...
iA Financial Group today announces that the Annual Shareholder Meeting of iA Financial Corporation Inc. ("iA Financial Corporation") and the Annual Meeting of the Sole Common Shareholder and of the Participating Policyholders of Industrial Alliance...